DK0671156T3 - Kosmetiske eller farmaceutiske præparater indeholdende liposomer - Google Patents

Kosmetiske eller farmaceutiske præparater indeholdende liposomer

Info

Publication number
DK0671156T3
DK0671156T3 DK95400322T DK95400322T DK0671156T3 DK 0671156 T3 DK0671156 T3 DK 0671156T3 DK 95400322 T DK95400322 T DK 95400322T DK 95400322 T DK95400322 T DK 95400322T DK 0671156 T3 DK0671156 T3 DK 0671156T3
Authority
DK
Denmark
Prior art keywords
aryl
halogen
cosmetic
opt
aralkyl
Prior art date
Application number
DK95400322T
Other languages
English (en)
Inventor
Jean-Luc Dubois
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Application granted granted Critical
Publication of DK0671156T3 publication Critical patent/DK0671156T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1277—Processes for preparing; Proliposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK95400322T 1994-02-16 1995-02-15 Kosmetiske eller farmaceutiske præparater indeholdende liposomer DK0671156T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9401755A FR2716110B1 (fr) 1994-02-16 1994-02-16 Compositions cosmétiques ou pharmaceutiques comprenant des liposomes.

Publications (1)

Publication Number Publication Date
DK0671156T3 true DK0671156T3 (da) 2002-02-04

Family

ID=9460135

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95400322T DK0671156T3 (da) 1994-02-16 1995-02-15 Kosmetiske eller farmaceutiske præparater indeholdende liposomer

Country Status (16)

Country Link
US (1) US6162444A (da)
EP (1) EP0671156B1 (da)
JP (1) JPH07309754A (da)
KR (1) KR100407902B1 (da)
CN (1) CN1149971C (da)
AT (1) ATE207337T1 (da)
AU (1) AU701344B2 (da)
CA (1) CA2141506A1 (da)
DE (1) DE69523356T2 (da)
DK (1) DK0671156T3 (da)
ES (1) ES2163478T3 (da)
FR (1) FR2716110B1 (da)
HU (1) HU218578B (da)
PT (1) PT671156E (da)
RU (1) RU2131731C1 (da)
ZA (1) ZA951281B (da)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1289939B1 (it) * 1997-02-20 1998-10-19 Angelini Ricerche Spa Composizione farmaceutica acquosa comprendente un principio attivo altamente insolubile in acqua
US6132582A (en) 1998-09-14 2000-10-17 The Perkin-Elmer Corporation Sample handling system for a multi-channel capillary electrophoresis device
PT1123082E (pt) * 1998-10-23 2006-06-30 Aventis Pharma Sa Preparacoes para aplicacao topica de substancias de actividade antiandrogenica
US20040077605A1 (en) 2001-06-20 2004-04-22 Salvati Mark E. Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
AU2001288213B2 (en) 2000-06-28 2005-04-14 Bristol-Myers Squibb Company Selective androgen receptor modulators and methods for their identification, design and use
US7001911B2 (en) 2000-06-28 2006-02-21 Bristol-Myers Squibb Company Fused cyclic modulators of nuclear hormone receptor function
EP1854798A3 (en) 2000-09-19 2007-11-28 Bristol-Myers Squibb Company Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
US6953679B2 (en) 2000-09-19 2005-10-11 Bristol-Myers Squibb Company Method for the preparation of fused heterocyclic succinimide compounds and analogs thereof
US20040087548A1 (en) 2001-02-27 2004-05-06 Salvati Mark E. Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
ES2310622T3 (es) 2001-12-19 2009-01-16 Bristol-Myers Squibb Company Compuestos heterociclicos condensados y analogos de los mismos, moduladores de la funcion de los receptores nucleares de hormonas.
DE10218963A1 (de) * 2002-04-27 2003-11-20 Aventis Pharma Gmbh Zubereitungen zur topischen Applikation von antiandrogen wirksamen Substanzen
US6875438B2 (en) * 2002-04-27 2005-04-05 Aventis Pharma Deutschland Gmbh Preparations for topical administration of substances having antiandrogenic activity
US20030215493A1 (en) * 2002-04-30 2003-11-20 Patel Pravin M. Composition and method for dermatological treatment
DE50211883D1 (de) * 2002-04-30 2008-04-24 Cognis Ip Man Gmbh Verwendung von Wirkstoffmischungen mit Azelainsäure und Glycyrrhetinsäure als Anti-Aknemittel
US20110142922A1 (en) * 2002-04-30 2011-06-16 Ferndale Ip, Inc. Stabilized composition and method for dermatological treatment
US20030219465A1 (en) * 2002-05-23 2003-11-27 Suresh Kumar Gidwani Composition for delivery of dithranol
US7074418B2 (en) * 2002-11-18 2006-07-11 Changaris David G Conjugated fatty acid based emulsion and methods for preparing and using same
DE10336841A1 (de) * 2003-08-11 2005-03-17 Rovi Gmbh & Co. Kosmetische Rohstoffe Kg Kosmetische Zusammensetzung zur Unterstützung des Sauerstofftransports in die Haut
US7407623B2 (en) * 2003-12-09 2008-08-05 Ge Betz, Inc. Steam condensate corrosion inhibitor compositions and methods
EA011391B1 (ru) * 2004-10-18 2009-02-27 Полимун Сайнтифик Иммунбиологише Форшунг Гмбх Липосомная композиция, содержащая активное вещество для релаксации гладкой мускулатуры, получение этой композиции и ее терапевтическое применение
EP1912679A4 (en) * 2005-06-15 2009-07-29 Massachusetts Inst Technology AMINOUS LIPIDS AND ITS USES
TW201111378A (en) 2009-09-11 2011-04-01 Bayer Schering Pharma Ag Substituted (heteroarylmethyl) thiohydantoins
RU2503446C2 (ru) * 2012-02-07 2014-01-10 Алексей Валентинович Одинцов Средство для роста волос (варианты) и способ лечения облысения
CN103965112A (zh) * 2014-05-13 2014-08-06 上海孚一生物科技有限公司 一种具有抗雄激素活性的化合物、制备方法及其应用
US11292782B2 (en) 2018-11-30 2022-04-05 Nuvation Bio Inc. Diarylhydantoin compounds and methods of use thereof
CN113024513A (zh) * 2021-03-22 2021-06-25 中国药科大学 新型雄激素受体降解剂、制备方法和医药用途

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2476087A1 (fr) 1980-02-18 1981-08-21 Roussel Uclaf Nouvelles oximes derivees de l'acide 3-alkyloxy ou 3-alkyl-thiomethyl 7-amino thiazolyl acetamido cephalosporanique, leur procede de preparation et leur application comme medicaments
FR2627385B3 (fr) * 1988-02-23 1991-08-23 Serobiologiques Lab Sa Composition notamment utile comme matiere de base pour la preparation de compositions pharmaceutiques, notamment dermatologiques et/ou cosmetiques
FR2631234B1 (fr) 1988-05-10 1990-09-14 Dior Christian Parfums Composition cosmetique ou dermatologique, notamment a action amincissante ou anti-cellulitique contenant des extraits de cola sous forme libre ou sous forme liposomale
US5204105A (en) * 1990-04-10 1993-04-20 Chanel, Inc. Cosmetic composition
DE4038075C1 (en) * 1990-11-29 1992-03-19 B. Braun Melsungen Ag, 3508 Melsungen, De Encapsulating solid or liq. lipophilic agents - comprises mixing hydration medium with phospholipid increasing temp. to above soln. phase change temp. and adding remaining medium
FR2671348B1 (fr) * 1991-01-09 1993-03-26 Roussel Uclaf Nouvelles phenylimidazolidines, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant.
FR2693461B1 (fr) * 1992-07-08 1994-09-02 Roussel Uclaf Nouvelles phénylimidazolidines substituées, leur procédé de préparation, leur application comme médicaments et les compositions pharmaceutiques les renfermant.
US5411981A (en) * 1991-01-09 1995-05-02 Roussel Uclaf Phenylimidazolidines having antiandrogenic activity
DE4207481A1 (de) * 1992-03-10 1993-09-16 Bayer Ag Liposomale wirkstoff-formulierungen und verfahren zu ihrer herstellung
US5358752A (en) * 1993-02-23 1994-10-25 Norac Technologies Inc. Skin care composition

Also Published As

Publication number Publication date
AU701344B2 (en) 1999-01-28
JPH07309754A (ja) 1995-11-28
CN1112416A (zh) 1995-11-29
FR2716110B1 (fr) 1996-04-05
PT671156E (pt) 2002-03-28
HUT72021A (en) 1996-03-28
AU1227795A (en) 1995-08-24
EP0671156A1 (fr) 1995-09-13
RU95101833A (ru) 1997-02-27
KR950031033A (ko) 1995-12-18
CA2141506A1 (fr) 1995-08-17
CN1149971C (zh) 2004-05-19
HU9500454D0 (en) 1995-04-28
ZA951281B (en) 1996-02-16
HU218578B (hu) 2000-10-28
EP0671156B1 (fr) 2001-10-24
FR2716110A1 (fr) 1995-08-18
ES2163478T3 (es) 2002-02-01
DE69523356D1 (de) 2001-11-29
ATE207337T1 (de) 2001-11-15
RU2131731C1 (ru) 1999-06-20
DE69523356T2 (de) 2002-07-11
US6162444A (en) 2000-12-19
KR100407902B1 (ko) 2004-03-09

Similar Documents

Publication Publication Date Title
DK0671156T3 (da) Kosmetiske eller farmaceutiske præparater indeholdende liposomer
HUP0102793A2 (hu) Agydaganat kezelésére szolgáló kinazolinok és ezeket tartalmazó gyógyszerkészítmények
DE69327438T2 (de) Therapeutische Mittel für die Parkinsonsche Krankheit
ATE179711T1 (de) 1,2-substituierte 1h-imidazo(4,5-c>chinolin-4- amine
DE69113604D1 (de) Quinoloncarbonsäurederivat.
FR2651122B1 (fr) Compositions destinees a etre utilisees pour freiner la chute des cheveux et pour induire et stimuler leur croissance, contenant des derives de l'amino-2 pyrimidine oxyde-3 et nouveaux composes derives de l'amino-2 pyrimidine oxyde-3.
DE69029627D1 (de) 4-(1'-Oxocyclohex-2'-yl)azetidin-2-on-Derivate
ATE156836T1 (de) 11,21-bisphenyl-19-nor-pregnan derivate
DE69600956T2 (de) N,N'-Di(aralkyl)-N,N'-di(2-azaaralkyl)alkylendiamin-Derivate und ihre Verwendung in pharmazeutischen und kosmetischen Zusammensetzungen
ATE137749T1 (de) Benzomorphane und ihre verwendung als arzneimittel
DE69006452D1 (de) Derivate und Analoge von Pyrimidon zur Behandlung von Asthma und bestimmte Hautkrankheiten.
TW330147B (en) Halogenobenzimidazoles, their preparation processes and their use
DE602004002792D1 (de) Paraphenylendiamin Derivate auf Basis einer zyklischen Diaza-Verbindung substituiert mit einem kationischen Radikal und Verwendung dieser Derivate zur Färbung von Keratinfasern